| # | Drug | Count |
|---|---|---|
| 0 | DULAGLUTIDE | 553 |
| 1 | ORAL SEMAGLUTIDE | 511 |
| 2 | METFORMIN | 404 |
| 3 | METFORMIN ER 500 MG | 398 |
| 4 | METFORMIN ER 750 MG | 398 |
| 5 | TIRZEPATIDE | 387 |
| 6 | CLOZAPINE | 211 |
| 7 | INSULIN GLARGINE | 198 |
| 8 | GABAPENTIN | 195 |
| 9 | OMEPRAZOLE MAGNESIUM | 189 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRYONIA (ALBA), CARDUUS MARIANUS, CHELIDONIUM MAJUS, HEPAR SUIS, TARAXACUM OFFICINALE | 1 | 0.0769 |
| 1 | BISMUTH SUBGALLATE | 1 | 0.0217 |
| 2 | CHLOROTHIAZIDE SODIUM | 7 | 0.0076 |
| 3 | ORAL SEMAGLUTIDE | 511 | 0.0065 |
| 4 | CHLOROTHIAZIDE | 8 | 0.0063 |
| 5 | DULAGLUTIDE | 553 | 0.0062 |
| 6 | PSYLLIUM HUSK | 7 | 0.0052 |
| 7 | PRUCALOPRIDE | 11 | 0.0046 |
| 8 | PLECANATIDE | 9 | 0.0043 |
| 9 | CHLORPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL | 1 | 0.0040 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 851 |
| 1 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 387 |
| 2 | Insulin Analog [EPC] | 286 |
| 3 | Atypical Antipsychotic [EPC] | 278 |
| 4 | Proton Pump Inhibitor [EPC] | 232 |
| 5 | Benzodiazepine [EPC] | 208 |
| 6 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 196 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 195 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 178 |
| 9 | Sulfonylurea [EPC] | 166 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Serotonin-4 Receptor Agonist [EPC] | 3 | 0.0046 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 9 | 0.0043 |
| 2 | Bismuth [EPC] | 14 | 0.0025 |
| 3 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 4 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 5 | GLP-1 Receptor Agonist [EPC] | 851 | 0.0019 |
| 6 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 196 | 0.0018 |
| 7 | Chloride Channel Activator [EPC] | 13 | 0.0014 |
| 8 | Sulfonylurea [EPC] | 166 | 0.0013 |
| 9 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |